These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1081 related items for PubMed ID: 27231801

  • 1. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
    Pauly NJ, Talbert JC, Brown J.
    J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ, Brown JD.
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [Abstract] [Full Text] [Related]

  • 3. The Prevalence and Predictors of Low-Cost Generic Program Use in the Pediatric Population.
    Pauly NJ, Talbert JC, Brown JD.
    Drugs Real World Outcomes; 2015 Dec; 2(4):411-419. PubMed ID: 26690285
    [Abstract] [Full Text] [Related]

  • 4. Empirical Assessment of the Impact of Low-Cost Generic Programs on Adherence-Based Quality Measures.
    Pauly NJ, Talbert JC, Brown JD.
    Pharmacy (Basel); 2017 Mar 08; 5(1):. PubMed ID: 28970427
    [Abstract] [Full Text] [Related]

  • 5. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A, Starner CI, Gunderson BW, Schafer JA, Qiu Y, Gleason PP.
    J Manag Care Pharm; 2012 Mar 08; 18(9):690-700. PubMed ID: 23206212
    [Abstract] [Full Text] [Related]

  • 6. The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population.
    Brown JD, Pauly NJ, Talbert JC.
    Pharmacy (Basel); 2016 Mar 04; 4(1):. PubMed ID: 28970387
    [Abstract] [Full Text] [Related]

  • 7. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD, Gonzales M, Rosenquist A, Miller TA, Gilmer TP, Best BM.
    J Manag Care Pharm; 2011 Apr 04; 17(3):213-23. PubMed ID: 21434698
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
    Daniel GW, Malone DC.
    J Manag Care Pharm; 2007 Mar 04; 13(2):142-54. PubMed ID: 17330975
    [Abstract] [Full Text] [Related]

  • 9. Unfilled Prescriptions of Medicare Beneficiaries: Prevalence, Reasons, and Types of Medicines Prescribed.
    Kennedy J, Tuleu I, Mackay K.
    J Manag Care Spec Pharm; 2020 Aug 04; 26(8):935-942. PubMed ID: 32715958
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Influence of a Community Pharmacy Automatic Prescription Refill Program on Medicare Part D Adherence Metrics.
    Lester CA, Mott DA, Chui MA.
    J Manag Care Spec Pharm; 2016 Jul 04; 22(7):801-7. PubMed ID: 27348281
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
    Mhatre SK, Serna O, Sansgiry S, Fleming ML, Essien EJ, Sansgiry SS.
    J Manag Care Spec Pharm; 2016 Nov 04; 22(11):1293-1301. PubMed ID: 27783546
    [Abstract] [Full Text] [Related]

  • 20. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC, Marcoux RM, Quilliam BJ.
    J Manag Care Pharm; 2010 Jun 04; 16(5):317-28. PubMed ID: 20518584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.